Claudio Marcocci Selected Research

Therapeutics

1/2023	Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
1/2023	Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.
1/2022	Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant.
7/2020	TSH suppressive therapy and bone.
1/2020	Selenium in the Treatment of Graves' Hyperthyroidism and Eye Disease.
1/2020	Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis.
1/2020	Antioxidant Therapy in Graves' Orbitopathy.
1/2020	A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature.
1/2020	Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism.
1/2020	Teprotumumab for the Treatment of Active Thyroid Eye Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudio Marcocci Research Topics

Disease

40	Graves Ophthalmopathy 01/2022 - 03/2002
21	Neoplasms (Cancer) 04/2024 - 03/2002
14	Hyperthyroidism 09/2021 - 12/2002
14	Primary Hyperparathyroidism 01/2020 - 03/2004
11	Hypercalcemia (Milk Alkali Syndrome) 01/2023 - 11/2003
11	Parathyroid Neoplasms (Parathyroid Neoplasm) 12/2021 - 03/2004
8	Hypocalcemia 01/2023 - 08/2017
8	Hypoparathyroidism 01/2023 - 08/2015
8	Vitamin D Deficiency 01/2023 - 11/2002
7	Osteoporosis 01/2022 - 11/2002
6	Exophthalmos (Proptosis) 01/2022 - 03/2002
6	Thyroid Diseases (Thyroid Disease) 01/2018 - 12/2002
5	Thyrotoxicosis 08/2022 - 05/2007
5	Graves Disease (Basedow Disease) 07/2019 - 12/2003
4	Hypothyroidism 08/2022 - 12/2003
4	Nephrolithiasis 01/2022 - 01/2019
4	Metabolic Bone Diseases (Osteopenia) 12/2021 - 11/2008
4	Eye Diseases (Eye Disease) 11/2021 - 04/2002
3	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 07/2012
3	Rare Diseases (Rare Disease) 01/2022 - 01/2018
3	Diabetes Mellitus 12/2021 - 01/2019
3	Hypercalciuria 12/2021 - 07/2018
3	Diplopia (Double Vision) 01/2020 - 11/2012
3	Multiple Endocrine Neoplasia Type 1 03/2018 - 01/2012
3	Goiter 04/2014 - 05/2005
3	Optic Nerve Diseases (Optic Neuropathy) 04/2012 - 03/2002
2	COVID-19 01/2023 - 12/2021
2	Prediabetic State (Prediabetes) 01/2023 - 01/2019
2	Parathyroid Diseases (Parathyroid Disorders) 01/2022 - 01/2012
2	Nephrocalcinosis 01/2022 - 07/2018
2	Infantile Hypercalcemia 12/2021 - 07/2018
2	Secondary Hyperparathyroidism 12/2021 - 04/2010
2	Myasthenia Gravis 06/2021 - 11/2008
2	Bone Diseases (Bone Disease) 01/2021 - 12/2011
2	Hyperphosphatemia 01/2021 - 03/2019
2	Carcinogenesis 01/2021 - 01/2016
2	Rickets (Rachitis) 12/2020 - 01/2019
2	Bone Resorption 07/2020 - 01/2018
2	Hypophysitis 10/2019 - 02/2019
2	Endocrine System Diseases (Endocrine Diseases) 02/2019 - 08/2015
2	Acromegaly 01/2019 - 11/2016
2	Osteomalacia 01/2019 - 08/2017
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2018 - 03/2018
2	Heart Failure 09/2018 - 12/2017
2	Hyperparathyroidism 03/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

20	CalciumIBA 01/2023 - 11/2002
17	Vitamin D FDA LinkGeneric 04/2024 - 12/2011
14	Parathyroid Hormone (Parathormone)IBA 01/2023 - 01/2006
14	GlucocorticoidsIBA 01/2023 - 08/2003
10	SeleniumIBA 01/2020 - 05/2011
7	AntioxidantsIBA 12/2020 - 05/2011
7	AutoantibodiesIBA 01/2020 - 05/2007
7	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2004
6	Thyrotropin Receptors (Thyrotropin Receptor)IBA 09/2021 - 12/2002
5	Vitamin D3 24-HydroxylaseIBA 01/2022 - 07/2018
5	AntibodiesIBA 09/2021 - 05/2007
4	Calcitriol (Calcijex)FDA LinkGeneric 01/2023 - 03/2019
4	Immune Checkpoint InhibitorsIBA 09/2021 - 07/2019
4	hydroxide ionIBA 01/2021 - 08/2012
4	Calcium-Sensing ReceptorsIBA 01/2020 - 03/2009
4	AutoantigensIBA 01/2018 - 12/2002
4	Cinacalcet (Sensipar)FDA Link 10/2014 - 08/2009
3	Thyroid HormonesIBA 08/2022 - 05/2005
3	AntigensIBA 12/2021 - 04/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021 - 01/2018
3	Monoclonal AntibodiesIBA 01/2020 - 02/2019
3	IodineIBA 10/2019 - 04/2014
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019 - 12/2004
3	Hormones (Hormone)IBA 12/2017 - 12/2003
3	Methimazole (Thiamazole)FDA LinkGeneric 10/2016 - 12/2003
3	Low Density Lipoprotein Receptor-Related Protein-2IBA 08/2006 - 12/2003
3	Troleandomycin (TAO)FDA Link 05/2005 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2021
2	teprotumumabIBA 01/2022 - 01/2020
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022 - 01/2021
2	Cholecalciferol (Vitamin D3)FDA Link 12/2021 - 08/2017
2	LDL CholesterolIBA 11/2021 - 01/2018
2	Apoptosis Regulatory ProteinsIBA 09/2021 - 01/2020
2	Polychlorinated Biphenyls (PCBs)IBA 01/2021 - 01/2016
2	Free RadicalsIBA 12/2020 - 05/2011
2	Oxygen (Dioxygen)IBA 12/2020 - 05/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 07/2012
2	Calcium Carbonate (Limestone)FDA Link 01/2020 - 01/2020
2	pembrolizumabIBA 01/2020 - 10/2019
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020 - 05/2007
2	Phosphates (Orthophosphate)IBA 01/2020 - 01/2018
2	25-hydroxyvitamin DIBA 01/2020 - 04/2010
2	NivolumabIBA 10/2019 - 07/2019
2	atezolizumabIBA 10/2019 - 02/2019
2	Calcifediol (Calcidiol)FDA Link 03/2019 - 08/2017
2	EnzymesIBA 07/2018 - 07/2012

Therapy/Procedure

25	Therapeutics 01/2023 - 05/2007
8	Parathyroidectomy 01/2020 - 03/2004
8	Decompression 10/2019 - 08/2005
6	Radiotherapy 08/2017 - 03/2002
4	Thyroidectomy 01/2020 - 05/2007
3	Immunotherapy 09/2021 - 10/2019
2	Bariatric Surgery 12/2021 - 08/2017
2	Transplantation 06/2021 - 03/2018
2	Kidney Transplantation 03/2018 - 04/2010